Phase II Clinical Trial of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer With Correlative Assessment of Hormone Intermediates.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 26 Feb 2018
At a glance
- Drugs Abiraterone acetate (Primary) ; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- 16 Feb 2018 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.
- 16 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Mar 2018.
- 10 Jun 2017 Biomarkers information updated